News | July 28, 2021
Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
The US business faced price erosion due to increased competition.
The company has reported PAT of Rs. 10.7 crore for Q1 FY22, higher by 23% YoY
The company has already embarked upon significant expansion in Turkey
The company reported total income of Rs.263.60 crores during the 12 months period ended March 31, 2021
The company has posted net profit of Rs.1.09 crores for the 12 months period ended March 31, 2021
ZyCoV-D had already exhibited a robust immunogenicity and tolerability and safety profile in the adaptive Phase I/II clinical trials
The company has reported total income of Rs.355.43 crores during FY 2020-21
The company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection
The agreements between the parties involve a total fee of Rs. 8 lakh plus taxes for the grant of the licenses on a non-exclusive basis to SPL
Subscribe To Our Newsletter & Stay Updated
